WS #3768

The dominant signal in this 10-minute window is the intensifying Iran-Israel conflict, with multiple sources reporting direct military escalations that threaten energy supplies and inflation. Jetstream reports indicate a double rocket strike on Haifa's oil refinery, corroborated by geopolitical chatter about US ground raid scenarios targeting Iranian coastal sites and Kharg Island, which handles 90% of Iran's oil exports. This aligns with previous warnings of Strait of Hormuz disruptions, likely exacerbating oil price surges and inflation fears. Concurrently, Bloomberg and jetstream note European consumers' inflation expectations have surged due to the war, pressuring the ECB and potentially weighing on indices like SPY and QQQ. Secondary signals include significant M&A activity and corporate developments. Jetstream reports Sysco's $29 billion acquisition of Restaurant Depot, with shareholders receiving $21.6 billion in cash and 91.5 million Sysco shares, which could move SYSCO stock. In biotech, Zymeworks received FDA Fast Track designation for ZW191, potentially boosting ZYME. Analyst actions include Needham initiating coverage on TSS with a Buy rating and $16 price target, and reiterating Buy on Boston Scientific with a $97 target, while BTIG reiterates Buy on Bright Minds Biosciences with a $147 target. These provide specific catalysts for affected tickers. Geopolitical and economic cross-currents include Myanmar's military leader moving closer to becoming president, which may impact regional stability, and Australia halving fuel tax for three months to shield consumers from surging costs, a direct policy response to energy price shocks. The Ethereum Foundation staking an additional $42 million of ETH indicates institutional crypto activity, though broader market impact is limited. Most other items, such as routine SEC filings, comparative industry analyses, and non-market news, are noise.